Ireland· IE-PA-EU/1/19/1407/003
Isturisa 10 mg film-coated tablets
A osilodrostat product containing osilodrostat, registered in Ireland by Recordati Rare Diseases. The same ATC class is registered in 14 of our 19 countries.
Checked against HPRA (Ireland) on
Informational only — not a medical device.
Where it is registered
Osilodrostat is registered in 14 of 19 countries.
Countries holding a registration under ATC H02CA02 (osilodrostat), each read from that country’s own register.
- This record: Ireland, from HPRA (Ireland)
- 10 of them publish a price we can compare per daily dose
Osilodrostat · ATC H02CA02
14 / 19 countries
- Belgiumprice
- Czechiaprice
- Denmark
- Finlandprice
- Franceprice
- Icelandprice
- Ireland
- Italyprice
- Netherlands
- Polandprice
- Spainprice
- Switzerlandprice
- United Kingdom
- United Statesprice
Price per daily dose
What a daily dose of osilodrostat costs, country by country.
Normalised to the WHO defined daily dose (10 mg), the median price runs from $0.21 in France to $389.38 in Italy — a ×1832 gap.
- 3 markets with a comparable price for this class
- Public list prices, converted to USD at the rate date shown
Osilodrostat · price per daily dose (10 mg)
USD · FX 28 Sept 2026
- IT Italy$389.38
- CH Switzerland$250.17
- FR France$0.21
The record
At a glance
HPRA (Ireland)- Active substance
- Osilodrostat
- Manufacturer
- Recordati Rare Diseases
- Country
- Ireland (IE)
- ATC code
- H02CA02
- ATC class
- Osilodrostat
- Defined daily dose
- 10 mg, O
- Reimbursed
- Not published by this register
- Source register
- HPRA (Ireland)
- Last checked
- September 28, 2026
Packs & prices · 1
- ie_pa_numberEU/1/19/1407/003
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
488 interactions on record for osilodrostat.
Graded by severity as the source publishes them — 117 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Osilodrostat · interactions on record
488 records
- 117 severe
- 361 moderate
- 10 minor
Most severe, free to view
- PapaverineA03AD01severe
- CisaprideA03FA02severe
- DolasetronA04AA04severe
- LonafarnibA16AX20severe
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Osilodrostat in 13 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- BelgiumIsturisa 10 mgRecordati Rare Diseases
- SwitzerlandIsturisa
- CzechiaISTURISARecordati Rare Diseases, Puteaux
- SpainISTURISA 10 mg COMPRIMIDOS RECUBIERTOS CON PELICULARecordati Rare Diseases
- FinlandIsturisaRecordati Rare Diseases
- FranceISTURISA 10 mg, comprimé pelliculéRECORDATI RARE DISEASES
- IcelandIsturisaRecordati Rare Diseases*
- NetherlandsIsturisa 10 mg filmomhulde tablettenRecordati Rare Diseases
Authorised across Europe · EMA
The same active substance is authorised in 3 EEA countries. Names it is sold under:
- Iceland · Isturisa
- Liechtenstein · Isturisa
- Norway · Isturisa
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of HPRA (Ireland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/790ba8be-ff38-4228-b1df-3ba0df48a0fa GET /v1/drugs/790ba8be-ff38-4228-b1df-3ba0df48a0fa?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Film-coated tablet",
"routes": [
"Oral use"
],
"source": "hpra",
"atc_all": [
"H02CA",
"H02CA02"
],
"strength": null,
"pa_number": "EU/1/19/1407/003",
"substances": [
"Osilodrostat"
],
"legal_basis": "Full application (Article 8(3) of Directive No 2001/83/EC)",
"market_info": "Unknown",
"authorised_at": "09/01/2020",
"dispensing_status": "Product subject to prescription which may not be renewed (A)",
"registration_status": "AU",
"supply_legal_status": "Supply through pharmacies only",
"interchangeable_code": null
}See everything about osilodrostat.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.